NKTR · Nektar Therapeutics · Documents
$38.62
-0.60 (-1.53%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.34B
Shares
34.14M
Volume · Oct 21
337.63K
Avg daily vol (3M)
1.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-10-01 | — | |
| Investor Event Transcript | — | 2026-10-01 | 2026-12-31 | |
| 8-K | — | 2026-09-25 | 2026-09-24 | |
| 8-K | — | 2026-09-08 | — | |
| 10-Q | — | 2026-08-14 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| 8-K | — | 2026-06-05 | — | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| 8-K | — | 2026-05-08 | — | |
| 10-Q | — | 2026-05-08 | 2026-03-31 | |
| 8-K | — | 2026-05-07 | — | |
| ARS | — | 2026-04-24 | 2025-12-31 | |
| DEFA14A | — | 2026-04-24 | — | |
| DEF 14A | — | 2026-04-24 | 2026-06-04 | |
| 8-K | — | 2026-04-23 | 2026-04-21 | |
| Investor Event Transcript | — | 2026-04-20 | 2026-06-30 | |
| 8-K | — | 2026-04-20 | — | |
| 8-K | — | 2026-04-20 | — | |
| 10-K | — | 2026-03-13 | 2025-12-31 | |
| 8-K | — | 2026-03-12 | — | |
| 8-K | — | 2026-02-13 | 2026-02-11 | |
| 8-K | — | 2026-02-10 | — | |
| 8-K | — | 2026-02-10 | — | |
| 8-K | — | 2026-01-27 | — | |
| 8-K | — | 2025-12-16 | — | |
| 8-K | — | 2025-11-21 | — | |
| S-3ASR | — | 2025-11-12 | — | |
| 8-K | — | 2025-11-10 | 2025-11-08 | |
| 10-Q | — | 2025-11-07 | 2025-09-30 | |
| 8-K | — | 2025-11-06 | — | |
| 8-K | — | 2025-09-18 | — | |
| 10-Q | — | 2025-08-08 | 2025-06-30 | |
| 8-K | — | 2025-08-07 | — | |
| 8-K | — | 2025-07-01 | 2025-06-30 | |
| 8-K | — | 2025-06-27 | 2025-06-24 | |
| 8-K | — | 2025-06-24 | — | |
| 8-K | — | 2025-06-06 | — | |
| 8-K | — | 2025-06-04 | — | |
| 8-K | — | 2025-05-28 | 2025-05-23 | |
| 10-Q | — | 2025-05-09 | 2025-03-31 | |
| 8-K | — | 2025-05-08 | — | |
| DEF 14A | — | 2025-04-25 | 2025-05-23 | |
| ARS | — | 2025-04-25 | 2024-12-31 | |
| PRE 14A | — | 2025-04-15 | 2025-05-23 | |
| 8-K | — | 2025-04-04 | 2025-04-03 | |
| S-3 | — | 2025-03-28 | — | |
| 8-K | — | 2025-03-28 | — | |
| 10-K | — | 2025-03-14 | 2024-12-31 | |
| 8-K | — | 2025-03-12 | — | |
| 8-K | — | 2025-02-24 | — |
Showing 1–50 of 148 filings
Key facts
CIK
906709
CUSIP
640268306
13F (30d)
14 filings
14 filers
Visit website
Investor relations